Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Indian J Ophthalmol
; 2009 May-Jun; 57(3): 241-2
Article
in En
| IMSEAR
| ID: sea-70491
Full text:
1
Index:
IMSEAR
Main subject:
Photochemotherapy
/
Retinal Diseases
/
Retinal Vessels
/
Telangiectasis
/
Vitreous Body
/
Humans
/
Male
/
Fluorescein Angiography
/
Visual Acuity
/
Retinal Neovascularization
Language:
En
Journal:
Indian J Ophthalmol
Year:
2009
Type:
Article